<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Inclusion body myositis: clinical and histopathological features of 36 patients</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">S</forename><surname>Beyenburg</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Neurologische Universitfitsklinik Bonn</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Zierz</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Neurologische Universitfitsklinik Bonn</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Jerusalem</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">Neurologische Universitfitsklinik Bonn</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">Inclusion body myositis: clinical and histopathological features of 36 patients</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">DCE0DEC8D43BAE824FC05CEF6B6CAE4D</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Inflammatory myopathies -Inclusion body myositis -Rimmed vacuoles IBM=inclusion body myositis</term>
					<term>CK=creatine kinase</term>
					<term>MHC = major histocompatibility complex</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Thirty-six patients (15 females, 21 males) with inclusion body myositis (IBM) were studied. The diagnosis was established according to clinical and histopathological criteria. Clinical features were insidious onset of slowly progressive muscle weakness and wasting-with depressed or absent tendon reflexes especially in the lower limbs. The pattern of muscle weakness was variable. The majority of patients (58%) showed proximal and symmetrical weakness usually most prominent in the legs. Isolated distal (6%) and asymmetrical weakness (19%) was less frequently observed. Myalgia occurred in 42% of the patients. The age at onset of symptoms ranged from 20 to 73 years (mean 47 years). Serum creatine kinase levels were normal (11%) or mildly elevated (89%). Needle electromyography revealed myopathic features in about 80% of the patients, and results of nerve conduction studies were normal in most of the cases. The predominant histopathological findings were numerous muscle fibers with rimmed vacuoles (100% of the patients), groups of atrophic fibers (92%), and inflammatory infiltrates (89%). The inflammatory infiltrates were located predominantly at endomysial sites and were composed mainly of T8 cells. Electron microscopy showed characteristic intracytoplasmic filamentous inclusions in all 36 cases. Immunosuppressive treatment in 16 patients failed to prevent disease progression in all but one patient with an associated Sj6gren's syndrome. It is concluded that the consistent combination of typical histopathological findings and characteristic clinical features offers a firm basis for the diagnosis of IBM. IBM should be suspected in any adult patient presenting with clinical signs of a chronic polymyositis unresponsive to immunosuppressive therapy. The etiology and pathogenesis of IBM remain to be established.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>It is now generally accepted that inclusion body myositis (IBM) is a distinct entity among the idiopathic inflammatory myopathies, which encompass polymyositis, dermatomyositis, and inclusion body myositis <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b60">61]</ref>. In 1967 Chou <ref type="bibr" target="#b8">[9]</ref> described inclusion bodies in muscle biopsy specimens of a patient clinically presenting as chronic polymyositis. The term IBM was first used by Yunis and Samaha <ref type="bibr" target="#b62">[63]</ref> for a slowly progressive neuromuscular disorder characterized histologically by the presence of "rimmed vacuoles" in a subsarcolemmal and/or intracytoplasmic position within skeletal muscle fibers. At the ultrastructural level intracytoplasmic and/or intranuclear filamentous inclusions were regarded as the hallmark of the disease.</p><p>IBM is frequent in North America where it may represent up to 28% of all inflammatory myopathies <ref type="bibr" target="#b38">[39]</ref>. In addition to several case reports of IBM (for review see <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b34">35)</ref>, some larger series focusing on clinicopathological aspects of IBM have been reported by American authors <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b52">53]</ref>. Lotz et al. <ref type="bibr" target="#b38">[39]</ref> studied 40 cases of IBM and concluded that it is a distinct entity in which characteristic clinical and histopathological features are consistently associated. According to their investigation, the characteristic clinical findings are: insidious onset of slowly progressive, painless, proximal muscle weakness with relatively early depression of the patellar reflex resulting from severe weakness of the quadriceps muscle, normal or mildly elevated serum creatine kinase (CK), EMG abnormalities consistent with inflammatory myopathy, and lack of response to prednisone treatment. Furthermore, there was no evidence for a hereditary muscle disorder in their patient population. The presence of the following histopathological features is necessary for the diagnosis of IBM : at least one rimmed vacuole per low-power field, at least one group of atrophic fibers per low-power field, an inflammatory infiltrate predominantly at endomysial sites, and demonstration of the typical filamentous inclusions by electron microscopy.</p><p>Clinicopathological studies by European authors have mostly been case reports <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b44">45,</ref><ref type="bibr" target="#b53">54,</ref><ref type="bibr" target="#b57">58]</ref> and some smaller series <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b35">36,</ref><ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b54">55]</ref>. Mhiri and Gheradi <ref type="bibr" target="#b42">[43]</ref> reported nine patients with rimmed vacuoles in skeletal muscle, five of whom were classified as IBM, representing 16% of adult idiopathic inflammatory myopathies in their laboratory.</p><p>In the present study, clinical, electrophysiological, and histopathological findings in 36 patients with IBM were analyzed to assess the applicability of the above diagnostic criteria. Furthermore, current knowledge about treatment and pathogenesis of the disease is reviewed.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients</head><p>Thirty-six patients were diagnosed between 1982 and 1992 as having IBM according to the clinical, electrophysiological, and pathological criteria as proposed by Lotz et al. <ref type="bibr" target="#b38">[39]</ref>. Clinical and electrophysiological information about the patients were collected from the medical records, which were critically reviewed concerning the following criteria: detailed history with special reference to onset and duration of symptoms at the time of diagnosis, family history, distribution and severity of muscle weakness and atrophy, associated symptoms (i.e., myalgia, paresthesia, dysphagia), and associated autoimmune diseases. Sixteen patients treated by immunosuppressants were followed for 6 months-4 years (mean 19.4 months). Follow-up examinations were performed every 6 months. In six of these patients muscle strength was also measured, using a tensiometrical method <ref type="bibr" target="#b0">[1]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Muscle biopsy, histochemistry, and immunocytochemistry</head><p>Open biopsies were taken from the biceps, quadriceps, or tibialis anterior muscle under local anesthesia. The muscle specimens were flash-frozen at -160Â°C in isopentane chilled by liquid nitrogen and were stored under liquid nitrogen for subsequent studies. The following stainings and cytochemical reactions were performed on 10-~tm cryostat serial cross-sections: hematoxylin and eosin, modified Gomori trichrome, NADH dehydrogenase, acid phosphatase, myoadenylate deaminase, ATPase at pH 9.4, 4.6, 4.2, periodic acid-Schiff reagents, oil red O, succinate dehydrogenase, cytochrome oxidase, and phosphofructokinase <ref type="bibr" target="#b15">[16]</ref>. For ultrastructural studies biopsy specimens were fixed in 5% glutaraldehyde in 0.2 mol cacodylate buffer and embedded in epon C <ref type="bibr" target="#b15">[16]</ref>. The biopsy specimens of 12 patients were studied immunocytochemically using an immunoperoxidase technique: 6-~tm cryostat serial cross-sections were incubated for 60 min at room temperature with the following monoclonal antibodies obtained from Becton-Dickinson (Mountain View, CA): Leu 4 (CD 3, all peripheral T cells), Leu 3 (CD 4, Thelper/inducer cells), Leu 2 (CD 8, T cytotoxic/ suppressor cells, some natural killer cells), Leu 11 (CD 16, natural killer cells), Leu 14 (CD 22, all peripheral B cells), Leu M-3 (CD 14, makrophages), HLA-DR (MHC II, B cells, makrophages, activated T cells), HLA-ABC (MHC I, endothelial cells, macrophages). The immunocytochemical procedure was performed according to the method described in detail by Arahata and Engel <ref type="bibr" target="#b1">[2]</ref>. Positive reaction for a surface antigen consisted of a rim of the reaction product around the cell. For quantitation, several mononuclear cell accumulations at endomysial sites in specimens of five patients were analyzed. The total number of mononuclear cells at endomysial sites was counted in the Gomri trichrome stained section of each patient. Subsequently, mononuclear cell subsets were counted in the immunoreacted consecutive sections <ref type="bibr" target="#b1">[2]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Laboratory studies</head><p>Serum levels of CK, aldolase, lactate dehydrogenase, erythrocyte sedimentation rate, and routine blood and urine tests were obtained in all patients. The following immunological studies were performed in 22 patients: complement studies, rheumatoid factor, antinuclear antibodies, anti-native DNA antibodies, anti-thyreoglobulin antibodies, anti-microsomal antibodies, immunoglobulins IgG, IgA, IgM, IgE, and serum/urine paraprotein bands.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical data</head><p>The age at onset of symptoms ranged from 20 to 73 years (mean 47 years). The duration of symptoms before biopsy diagnosis varied from 1 to 15 years with an average of 6.1 years. There was a slight male predominance in our patient population (male:female ratio 1.4: l). There was no evidence of a hereditary neuromuscular disease. Associated autoimmune disease occurred in one patient who was diagnosed as Sj6gren's syndrome. None </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Laboratory studies</head><p>Serum CK levels varied from 44 to 988 U/1 with a mean of 279 U/I. CK was normal in four patients (11%) but was mildly or moderately elevated in the other patients (Fig. <ref type="figure">1</ref>). </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Electrophysiology</head><p>Needle EMG and motor and sensory nerve conduction studies were performed in all patients. Both distal and proximal muscles of upper and lower limbs were examined in each patient. EMG findings were abnormal in all 36 cases. In the vast majority of patients (29/36, 81%) myopathic EMG patterns were observed, that is, motor unit potentials of short duration and small amplitude and a full interference pattern. Only two patients (5%) had neurogenic EMG changes, consisting of long duration and high amplitude motor unit potentials and reduced interference patterns. Most of the long duration potentials were also polyphasic. Abnormal spontaneous activity (i.e., fibrillation potentials, positive sharp waves, and/or complex repetitive discharges) occurred in all patients. In five patients (14%) there was a mixed pattern of both myopathic and neurogenic changes with both short-and long-duration potentials in the same muscle. Nerve conduction studies were normal in all but three cases: in one patient sensory nerve conduction velocity of the ulnar nerve showed mild slowing. Motor nerve conduction velocities were normal. In another case there was a prolonged distal latency of the median nerve, and the patient with associated Sjtgren's syndrome showed mild slowing of sensory nerve conduction velocities.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Histopathology</head><p>The light microscopic features are listed in Table <ref type="table" target="#tab_2">2</ref>.</p><p>The pathological findings were regarded as significant for the disease only when they were observed frequently and represented predominant changes. The characteristic and most frequent histopathological features were numerous fibers with vacuoles in a subsarcolemmal or intracytoplasmic position rimmed or lined by granular, basophilic material (Figs. 2 A, 3 A), groups of atrophic fibers (Fig. <ref type="figure">2 B</ref>), and inflammatory infiltrates located predominantly at endomysial sites (Fig. <ref type="figure">3 C</ref>). Accumulations of the inflammatory cells at perimysial and perivascular sites were rare. Monoclonal antibody analysis of mononuclear endomysial cells in five patients revealed a T cell predominance (65.6 +_4.5% of all mononuclear cells; Fig. <ref type="figure">3</ref>  plasm usually near to the whorls of cytomembranes (Fig. <ref type="figure">4 A, B</ref>). The rimmed vacuoles seen by light microscopy corresponded to these whorls of cytomembranes. In addition, the filaments were often surrounded by other cytoplasmic degradation products, i.e., myeloid structures and glycogen granules. As previously described <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b43">44]</ref>, the filaments were curved or rectilinear in shape, measuring 15 19 nm in diameter.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Therapy</head><p>Sixteen patients were treated with prednisone for at least 6 months. The initial dose level consisted of 80-100 mg/day for 6-8 weeks. Subsequently the dosage was gradually tapered over a period of 6 months following an alternate-day program <ref type="bibr" target="#b24">[25]</ref>.</p><p>A maintenance dose consisted of 10-15 mg every second day. Seven patients received an additional trial of azathioprine (150 rag/day) for at least 6 months. The majority of patients reported only some slight temporary improvement of muscle strength. However, there was no objective response to therapy. Based on clinical follow-up examinations and testing of muscle strength the disease was slowly progressive in all but one treated patient. The patient with associated Sj6gren's syn- drome showed an excellent response to a treatment protocol consisting of prednisone and azathioprine for more than 2 years after initiation of therapy. Within 3 months CK levels had decreased from 693 U/1 to normal and muscle strength had improved. In four other patients serum CK levels transiently decreased significantly without concomitant clinical improvement. CK levels in these five patients ranged from 144 to 988 U/1 (mean 597 U/l) before initiation of treatment and decreased after 6-12 weeks to a mean of 195 U/1 and subsequently increased again during the following months. In the rest of the treated patients serum CK levels varied from 44 to 260 U/1 (mean 123 U/l) and showed no significant decrease during therapy, whereas in the 20 untreated patients CK levels ranged between 67 and 713 U/1 (mean 285 U/l).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical features</head><p>The main clinical features of inclusion body myositis are the slow progression of symmetrical and mainly proximal muscle weakness and atrophy, the occasional occurrence of asymmetrical and distal weakness, lack of response to prednisone therapy, normal or mildly elevated serum CK levels, and in contrast to polymyositis and dermatomyositis a less frequent association with systemic autoimmune diseases. Essentially, the clinical features of our patients did not differ from the largest series of patients recently described <ref type="bibr" target="#b38">[39]</ref>. In the present study the average age at onset was 47 years, and a slight male predominance was observed (male: female ratio 1.4: 1). This is consistent with previous series <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b52">53]</ref>, although onset after the age of 50 years and male predominance were more common in the patients described by Lotz etal. (male:female ratio 3:1) <ref type="bibr" target="#b38">[39]</ref>. The long duration (mean 6.1 years) between onset of symptoms and definite diagnosis reflects disease chronicity and difficulties in establishing the diagnosis of IBM. Myalgia occurred in 42% of our patients, being more frequent than described before <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b52">53]</ref>, and did not respond to corticosteroid therapy. Facial weakness, occurring in the present series in 11% of the cases, was also rare in other reported patients with IBM <ref type="bibr" target="#b43">[44,</ref><ref type="bibr" target="#b52">53]</ref>. Consistent with previous studies, cranial nerve abnormalities and extraocular muscle involvement were not observed.</p><p>Dysphagia was rare in our patients (14%), although it has been described to be present in up to 40% of the cases with IBM <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b52">53]</ref>. The dysphagia might be caused by cricopharyngeus muscle involvement and has recently been reported in patients with IBM. Recognition of severe dysphagia is important since appropriate surgical treatment via cricopharyngeus myotomy may improve this symptom <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b58">59]</ref>.</p><p>The pattern of muscle weakness was proximal and symmetrical in 58% of our patients. Severe weakness was almost always associated with muscular wasting. An asymmetrical distribution of weakness and involvement of both proximal and distal muscle groups of the same patient was common (Table <ref type="table" target="#tab_0">1</ref>). Usually the weakness was greatest in the legs, commonly associated with depression of lower limb deep tendon reflexes. These findings are consistent with data from 40 patients with IBM, where the relatively early depression of patellar reflexes was emphasized <ref type="bibr" target="#b38">[39]</ref>. Weakness of dis-tal muscles has been described in IBM <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b52">53]</ref>. Of our patients 42% showed involvement of distal muscles, but in the majority proximal weakness was greater than that of distal muscles, and only two patients (6%) presented with isolated distal weakness. Essentially, these observations are consistent with the findings of Lotz et al. <ref type="bibr" target="#b38">[39]</ref>. Of their patients 48% presented with some distal weakness, but proximal weakness was found in 90%, and distal weakness was as great or greater than proximal weakness in only 35% <ref type="bibr" target="#b38">[39]</ref>. Thus, the clinical picture of IBM, in which muscle weakness and atrophy develop and progress slowly, may resemble chronic polymyositis or limb girdle muscular dystrophy. Especially when the weakness is asymmetrical or distal, and CK levels are not increased, IBM may also mimic lower motor neuron syndromes.</p><p>In the present series, levels of serum CK and other serum muscle enzymes were normal or mildly to moderately elevated. CK levels above 1000 U/1 were never observed, and 11% of our 36 patients showed normal CK values. The erythrocyte sedimentation rate was normal in 95% of cases. These data are consistent with previously reported studies <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b52">53]</ref> indicating that extensive laboratory investigations are not helpful in establishing the diagnosis of IBM.</p><p>IBM is associated with systemic autoimmune disease in up to 15% of the cases including idiopathic interstitial pneumonitis, psoriasis, dermatomyositis, systemic lupus erythematosus, chronic immune thrombocytopenia, and rheumatoid arthrifts <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b41">42,</ref><ref type="bibr" target="#b50">51,</ref><ref type="bibr" target="#b61">62]</ref>. Although four out of 22 tested patients (18 %) showed some abnormal immunologic laboratory values, in only one patient was Sj6gren's syndrome diagnosed as a possible associated autoimmune disease. Thus, the incidence of associated autoimmune diseases in our patients with IBM is lower than that reported by Lotz et al. <ref type="bibr" target="#b38">[39]</ref>. There are only two other reported cases of IBM associated with Sj6gren's syndrome <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b21">22]</ref>, and these patients did not respond to immunosuppressive treatment. The authors suggested that immune mechanisms may play an important role in the pathogenesis of IBM. Lotz et al. <ref type="bibr" target="#b38">[39]</ref> reported six patients who were suffering from a malignancy, but in only two of them was there a close temporal association with IBM. None of our patients showed evidence of a malignant disease. Family history was unremarkable in all patients. The vast majority of reported patients with IBM showed no evidence for a hereditary neuromuscular disease. However, familial cases of IBM have been reported, suggesting autosomal recessive <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b39">40]</ref> or autosomal dominant inheritance <ref type="bibr" target="#b45">[46]</ref>. Furthermore, the description of familial cases of IBM with childhood onset <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b40">41,</ref><ref type="bibr" target="#b51">52]</ref> and a familial IBM with associated leukoencephalopathy <ref type="bibr" target="#b11">[12]</ref> indicates that there is a genetic heterogeneity of the disease.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Electrophysiological features</head><p>Neurogenic features in some cases of IBM have been described in detail according to electrophysiological and muscle and nerve biopsy investigations <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b36">37,</ref><ref type="bibr" target="#b52">53]</ref>. The vast majority of our patients (81%) showed myopathic changes on EMG examination indicating a primary myopathy, while clearly neurogenic abnormalities were detected in only two cases (5%). In addition to these observations, motor and sensory nerve conduction velocities and sensory nerve action potential amplitudes were normal in most cases, arguing against a concomitant neuropathy in IBM. However, these electrophysiological data do not exclude a neurogenic element in some cases. Five patients (14%) had mixed neurogenic and myopathic EMG abnormalities in single muscles, a pattern previously regarded as suggestive of IBM <ref type="bibr" target="#b27">[28]</ref>. The presence of mixed myopathic and neurogenic potentials accompanied by abnormal spontaneous activity has been demonstrated in about one-third of IBM patients in a detailed electrophysiological investigation of 30 patients with IBM, while 57% of these cases showed myopathic abnormalities and in only 7% of the patients solely neurogenic EMG changes were observed. Of these cases 33% showed some slowing of nerve conduction velocities <ref type="bibr" target="#b27">[28]</ref>. Eisen et al. <ref type="bibr" target="#b16">[17]</ref> found electromyographic signs of axonal neuropathy in about 30% of their IBM patients. Thus, IBM shows heterogeneous electrophysiological features which might be nonspecific because similar EMG patterns have been observed in patients with chronic polymyositis <ref type="bibr" target="#b38">[39]</ref>. Although most of the electrophysiological findings in IBM indicate a myopathy, some of the reported features suggest a neurogenic component as well.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Histopathological features</head><p>As noted in previous studies <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b52">53]</ref>, the histological hallmarks of IBM in our patients were rimmed vacuoles in numerous muscle fibers, grouped fiber atrophy with some angulated fibers, and mononuclear cell infiltrates consisting predominantly of T8 lymphocytes. These cells were located mainly at endomysial sites (75% of the patients) and less marked at perimysial (28% of the patients) and perivascular sites (19% of the patients). Further morphological features included a marked variation in fiber size (fiber diameter from 5 to 220 txm), frequently occurring necrotic fibers undergoing phagocytosis, and degenerating or regenerating muscle fibers. In addition to the occasionally observed electrophysiological features of denervation, some morphological findings further support a neurogenic element of the disease (i.e., grouped fiber atrophy and small dark or small angulated fibers, seldom target fibers). The presence of muscle fiber hypertrophy and the relatively high proportion of small angulated fibers appears to be an important histopathological feature in muscle biopsies from IBM patients, probably reflecting the chronic course of the disease <ref type="bibr" target="#b59">[60]</ref>. The immunopathologic findings support the notion that the inflammatory reaction in IBM represents a T cell mediated immune response resulting in muscle fiber injury as previously demonstrated for IBM and polymyositis <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b52">53]</ref>. Electron microscopy revealed characteristic filamentous inclusions in the cytoplasm. The vacuoles appear to be filled with granular material which on electron microscopy consists of myeloid structures and membranous whorls. The presence of more than one rimmed vacuole and more than one group of atrophic fibers per low-power field together with an endomysial inflammatory infiltrate is thought to be predictive of the presence of typical filamentous inclusions in 93% of the cases <ref type="bibr" target="#b38">[39]</ref>. However, the IBM type of filamentous inclusions may not be entirely specific of the disease because they may occasionally be observed in various other neuromuscular disorders <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b43">44]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Pathogenesis</head><p>The cause of IBM is unknown. The rare association with other systemic autoimmune diseases in some cases and the evidence for a T cell mediated cytotoxicity suggest that autoimmune mechanisms might play an important role in the pathogenesis of IBM. Detailed monoclonal antibody analysis of mononuclear cells in myopathies has led to the conclusion that antigen-specific, MHCrestricted T cell mediated cytotoxicity is part of the immune effector response in IBM and polymyositis <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b18">19]</ref>. This conclusion is supported by the presence of autoinvasive T8 cells which along with macrophages initially surround nonnecrotic muscle fibers and eventually invade and destroy these fibers. It has been suggested that the autoinvasive T8 cells had previously been sensitized to an antigen associated with the muscle fiber surface membrane. In addition to these findings, it has been demonstrated that muscle fibers either next to or remote from the inflammatory infiltrates express the class I major histocompatibility complex (MHC-I) antigen <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b30">31]</ref> (Fig. <ref type="figure">3D</ref>). Since cytotoxic T cells recognize antigens in association with MHC-I antigen, these observations suggest that in IBM and polymyositis the primary immunopathologic mechanism is mediated by cytotoxic T cells and is restricted to MHC-I antigen. However, factors or agents that trigger MHC-I antigen expression as well as the putative target antigen recognized by T cells are still undefined. Because sarcolemmal MHC-I expression can also be demonstrated on regenerating muscle fibers in various myopathies <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b30">31]</ref>, increased MHC-I expression may not be the primary mechanism in activation of cell-mediated cytotoxicity. Furthermore, the presence of perivascular B and T4 cells might indicate stimulation of antibody-secreting B cells by T helper cells and hence point to an additional humoral mechanism in the pathogenesis of IBM and polymyositis <ref type="bibr" target="#b18">[19]</ref>.</p><p>The nature of the filamentous inclusions and the mechanism of rimmed vacuole formation remain unclear. It has been speculated that viruses are involved in the pathogenesis of IBM <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b44">45]</ref> and might represent a possible triggering agent for the immune response in IBM. The view that the filamentous inclusions represent mumps viral particles <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref> was rejected by subsequent studies <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b46">47,</ref><ref type="bibr" target="#b49">50]</ref>. The role of altered intracellular proteins for rimmed vacuole formation has been emphasized in recent studies; the presence of strong ubiquitin immunoreactivity localized to the cytoplasmic filamentous inclusions led to the hypothesis that accumulation of ubiquitin is involved in the pathogenesis of IBM. The ubiquitinmediated turnover pathway is important for targeting a selective breakdown of abnormal or shortlived normal proteins and may play a role in modification of cellular proteins <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b4">5]</ref>. Furthermore, there is evidence that lysosomal proteinases are increased in muscle biopsies of patients with IBM <ref type="bibr" target="#b26">[27]</ref>. Strong immunoreactivity of the lysosomal proteinase cathepsin L localized to rimmed vacuoles indicates that cathepsin L is involved in the degeneration of muscle fibers, and that rimmed vacuole formation might be the result of autodigestion of myofilaments <ref type="bibr" target="#b26">[27]</ref>. However, this finding is not confined to muscles of IBM patients and may also be present in other myopathies associated with rimmed vacuoles <ref type="bibr" target="#b26">[27]</ref>. Rimmed vacuoles also stain for Congo red and contain green-birefringent intracellular amyloid deposits, suggesting that the IBM type of inclusions share properties with amyloid proteins, which might indicate an accumulation of an altered protein synthesized within the cell <ref type="bibr" target="#b41">[42]</ref>. Another interesting aspect is that the filaments in IBM resemble prion proteins. Therefore, a possible relationship of IBM to human prion disorders has been discussed <ref type="bibr" target="#b41">[42]</ref>. However, the significance of these findings is at present uncertain, and the etiology of IBM remains undefined.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Treatment</head><p>Our results confirm previous reports that corticosteroid therapy as well as azathioprine is ineffective in IBM <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b34">35,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b52">53]</ref>. However, immunosuppressive therapy may be helpful in some patients, especially if there is evidence of an associated systemic autoimmune disease <ref type="bibr" target="#b33">[34,</ref><ref type="bibr" target="#b61">62]</ref>. In the present study the patient with associated Sj6gren's syndrome showed a remarkable response to immunosuppressive treatment. However, a temporary or even sustained improvement in clinical symptoms has been described in some patients without any associated autoimmune diseases <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b28">29]</ref>. Lotz et al. <ref type="bibr" target="#b38">[39]</ref> analyzed data on 29 patients who had prednisone therapy for 3 months with at least 40 mg/day. They observed improvement in muscle strength and decreasing CK levels in only one patient after 5 months. Twenty-five of these patients followed for 2 or more years showed chronic progressive weakness despite therapy. Because some patients do improve on immunosuppressive treatment, at least one trial of prednisone or a combined therapy consisting of prednisone and azathioprine should be conducted. However, the number of reported IBM patients who have received immunotherapy is still small, and controlled therapeutic trials are pending. Alternative agents which might be considered for therapy are methotrexate, cyclosporin, cyclophosphamide, and high-dose intravenous immunoglobulin.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Differential diagnosis</head><p>The differential diagnosis between IBM and other slowly progressive neuromuscular disorders may be extremely difficult. Essentially, the differential diagnosis comprises chronic forms of polymyositis, sporadic forms of limb girdle muscular dystrophy, spinal muscular atrophy, and motor neuron diseases. The clinical differential diagnosis of idiopathic inflammatory myopathies includes myopathies associated with malignomas, myopathies due to infections of muscle, late-onset congenital myopathies, polymyalgia rheumatica, and metabolic, toxic or endocrine myopathies <ref type="bibr" target="#b24">[25]</ref> </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig</head><label></label><figDesc>Fig. 4A, B. Electron micrographs showing intracytoplasmic filamentous inclusions in IBM. A Mass of abnormal filaments in the cytoplasm (original magnification x 7000). B Rimmed vacuoles consisting of a conglomeration of myelin figures and some filamentous inclusions surrounded by myelin figures and cytoplasmic degradation products. Left, normal myofibrils (original magnification x 7000)</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>Clinical features of 36 patients with IBM at the time of diagnosis</figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>12</cell><cell></cell></row><row><cell>Symptoms</cell><cell>n</cell><cell>%</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Weakness Atrophy Myalgia</cell><cell>35 30 15</cell><cell>97 83 42</cell><cell cols="2">10 tJ 8 c k~</cell><cell></cell></row><row><cell>Paresthesia</cell><cell>5</cell><cell>14</cell><cell>"S</cell><cell></cell><cell></cell></row><row><cell>Dysphagia Facial weakness</cell><cell>5 4</cell><cell>14 11</cell><cell>.o E D</cell><cell>6</cell><cell></cell></row><row><cell cols="2">Deep tendon reflexes (reduced or absent)</cell><cell></cell><cell>z</cell><cell>4</cell><cell></cell></row><row><cell>Upper limbs</cell><cell>12</cell><cell>33</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Lower limbs</cell><cell>33</cell><cell>92</cell><cell></cell><cell>2</cell><cell></cell></row><row><cell>Pattern of weakness and atrophy</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Proximal Distal</cell><cell>21 2</cell><cell>58 6</cell><cell></cell><cell>0</cell><cell>0</cell><cell>100 200 300 400 500 600 700 800 900 1000</cell></row><row><cell>Proximal/distal</cell><cell>13</cell><cell>36</cell><cell></cell><cell></cell><cell></cell><cell>Serum-CK [IU/L]</cell></row><row><cell>Asymmetrical</cell><cell>7</cell><cell>19</cell><cell cols="4">Fig. 1. Serum CK levels in 36 patients with IBM. The normal</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="4">values were below 80 U/1 in males and below 70 U/1 in females.</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="4">Four patients had normal CK values</cell></row><row><cell cols="3">had stigmata of malignancy. The clinical findings</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">at the time of diagnosis are summarized in Table 1.</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">The depressed tendon reflexes correlated well with</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">the severity of muscle weakness and atrophy. The</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">majority of patients had proximal and symmetrical</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">weakness, usually greatest in the lower limbs. Only</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">seven patients had asymmetrical weakness in the</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">arms and/or legs. Facial weakness was rare (11%).</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">Myalgia occurred in 42% of the cases, and five</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">patients were suffering from dysphagia. Only five</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">patients complained of numbness and paresthesia</cell><cell></cell><cell></cell><cell></cell></row><row><cell>in distal parts of their limbs.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2</head><label>2</label><figDesc></figDesc><table><row><cell cols="3">. Histopathologic features in muscle biopsies of 36 pa-</cell></row><row><cell>tients with IBM</cell><cell></cell><cell></cell></row><row><cell>Histology</cell><cell>n</cell><cell>%</cell></row><row><cell>Variation in fiber size</cell><cell>36</cell><cell>100</cell></row><row><cell>Fibers with rimmed vacuoles</cell><cell>36</cell><cell>100</cell></row><row><cell>Atrophic fibers</cell><cell>33</cell><cell>92</cell></row><row><cell>Inflammatory infiltrates</cell><cell>32</cell><cell>89</cell></row><row><cell>Endomysial sites</cell><cell>24</cell><cell>75</cell></row><row><cell>Perimysial sites</cell><cell>9</cell><cell>28</cell></row><row><cell>Perivascular sites</cell><cell>6</cell><cell>19</cell></row><row><cell>Connective tissue proliferation</cell><cell>29</cell><cell>81</cell></row><row><cell>Muscle fiber degeneration</cell><cell>25</cell><cell>69</cell></row><row><cell>Central nuclei</cell><cell>23</cell><cell>64</cell></row><row><cell>Small dark fibers</cell><cell>17</cell><cell>47</cell></row><row><cell>Small angulated fibers</cell><cell>13</cell><cell>36</cell></row><row><cell>Muscle fiber regeneration</cell><cell>15</cell><cell>42</cell></row><row><cell>Grouping of fiber types</cell><cell>5</cell><cell>14</cell></row><row><cell>Target fibers</cell><cell>3</cell><cell>8</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>. The histological hallmark of IBM (rimmed vacuoles) â¢ occasionally occurs in other neuromuscular dis- orders. For example, rimmed vacuoles can occa- sionally be observed in neurogenic muscle atrophy, Kugelberg-Welander disease, congenital myopath- ies, and metabolic myopathies [21, 44]. In addition to IBM, they are frequently found in oculopharyn- geal dystrophy and various distal myopathies. Sim- ilarly, the characteristic filamentous inclusions have also been reported in various neuromuscular disorders, especially in several distal myopathies and oculopharyngeal dystrophy [21, 37, 41, 44, 48, 49, 56, 57].</head><label></label><figDesc></figDesc><table /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgement. The excellent technical assistance of Mrs.</head><p>Karen Tolksdorf is gratefully acknowledged.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Quantitative motor assessment in amyotrophic lateral sclerosis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Andres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hedlund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Finison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Conlon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Felmus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Munsat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="937" to="941" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by Tcells</title>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="193" to="208" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Rimmed vacuole myopathy&quot; sparing the quadriceps. A unique disorder in Iranian Jews</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Argov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Yarom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="33" to="43" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body rnyositis and oculopharyngeal muscular dystrophy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Serdaroglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="73" to="76" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light microscopic distinction from polymyositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Serdaroglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="460M" to="4661" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Inclusion body myositis presenting as treatment-resistant polymyositis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Calabrese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mitsumoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Chou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="397" to="402" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Heller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Eisen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="8" to="17" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Inclusion body myositis associated with Sj6gren&apos;s syndrome</title>
		<author>
			<persName><forename type="first">D</forename><surname>Chad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Good</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Adelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Bradley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mills</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="186" to="188" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Myxovirus-like structures in a case of human chronic polymyositis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Chou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="1453" to="1455" />
			<date type="published" when="1967">1967</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Inclusion body myositis. A chronic persistent mumps myositis?</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Chou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="765" to="777" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Clinical heterogeneity and treatment response in inclusion body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Sulaiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Garancis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Wortman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="734" to="740" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy</title>
		<author>
			<persName><forename type="first">A J</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kuzniecky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Andermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Andermann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="1025" to="1037" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Polymyositis, dermatomyositis, and inclusion-body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="page" from="1487" to="1498" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Inclusion body myositis associated with progressive dysphagia: treatment with cricopharyngeal myotomy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Danon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Friedmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="436" to="438" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Inclusion body myositis. A corticosteroidresistant inflammatory myopathy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Danon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Reyes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">H</forename><surname>Perurena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Masdeu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Manaligod</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="760" to="764" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title level="m" type="main">Muscle biopsy. A practical approach</title>
		<author>
			<persName><forename type="first">V</forename><surname>Dubowitz</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1985">1985</date>
			<pubPlace>Ballibre Tindall, London</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Inclusion body myositis (IBM): myopathy or neuropathy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Eisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gibson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1109" to="1114" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="209" to="215" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Mononuclear cells in myopathies : quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="704" to="721" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product</title>
		<author>
			<persName><forename type="first">D</forename><surname>Figarella-Branger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Pellisier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bianco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Devictor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Toga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aeta Neuropathol</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="528" to="536" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Rimmed vacuoles</title>
		<author>
			<persName><forename type="first">N</forename><surname>Fukuhara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kumamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tsubaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol (Bed)</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="229" to="235" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Inclusion body myositis and Sj6gren&apos;s syndrome</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gutmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Govindan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Riggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Schochet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1021" to="1022" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Dbficit moteur trbs lentement progressif prbdominant aux membres inf6r-ieurs chez un homme de 47 ans</title>
		<author>
			<persName><forename type="first">D</forename><surname>Herson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Serratrice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fms</forename><surname>Tomb</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Neurol</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="769" to="775" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: an example of diagnostic electron microscopy</title>
		<author>
			<persName><forename type="first">G</forename><surname>Hfibner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pongratz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Cellulaire</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="283" to="286" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">F</forename><surname>Jerusalem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zierz</surname></persName>
		</author>
		<author>
			<persName><surname>Muskelerkrankungen</surname></persName>
		</author>
		<imprint>
			<pubPlace>Stuttgart</pubPlace>
		</imprint>
	</monogr>
	<note type="report_type">Klinik-Therapie-Pathologie. Thieme</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Virus-/ihnliche Einschlfisse bei chronischen neuro-muskul/iren Prozessen. Elektronenmikroskopische Biopsiebefunde von 2 Ffillen</title>
		<author>
			<persName><forename type="first">F</forename><surname>Jerusalem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Baumgartner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wyler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Psychiatr Nervenkr</title>
		<imprint>
			<biblScope unit="volume">215</biblScope>
			<biblScope unit="page" from="148" to="166" />
			<date type="published" when="1972">1972</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Strong immunoreactivity of cathepsin L at the site of rimmed vacuoles in diseased muscles</title>
		<author>
			<persName><forename type="first">T</forename><surname>Jimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Satoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Takeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shibuya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wakayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sugita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="249" to="275O" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Electrophysiological spectrum of inclusion body myositis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Joy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Baysal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="949" to="951" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Inclusion body myositis. Clinical, biological and ultrastrucrural study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Julien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Vital</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Vallat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lagueny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sapina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="15" to="24" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Inclusion body myositis and paramyxoviruses</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kallajoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hyypi/I</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Halonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rvell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Rima</forename><forename type="middle">B</forename><surname>Kalimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="2" to="32" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Expression of immunoreactive maj or histocompatibility complex products in human skeletal muscles</title>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Pouliot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="64" to="72" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Inclusion body myositis. A &quot;slow-virus&quot; infection of skeletal musculature ?</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">P</forename><surname>Ketelsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Beckmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zimmermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Klin Wochenschr</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1063" to="1066" />
			<date type="published" when="1977">1977</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Inclusion body myositis : electrodiagnostic and nerve biopsy findings</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Lacy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Neville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Ringel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page">A202</biblScope>
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
	<note>Suppl 2</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: a case with associated collagen vascular disease responding to treatment</title>
		<author>
			<persName><forename type="first">Rjm</forename><surname>Lane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Fulthorpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hudgson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Neurosurg Psychiatr</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="270" to="273" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: Case reports and a reappraisal of an underrecognized type of inflammatory myopathy</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Lazaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Barton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Dentinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Lava</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mt Sinai J Med</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="137" to="144" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: peripheral nerve involvement. Combined morphological and electrophysiological studies on peripheral nerves</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hedstr6m</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="327" to="338" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Inclusion body myositis and Welander distal myopathy: a clinical, neurophysiological and morphological comparison</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Borg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Edstr6m</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hedstr6m</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="76" to="81" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Klinik and Morphologie der sog</title>
		<author>
			<persName><forename type="first">G</forename><surname>Lisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pongratz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hfibner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wallesch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Fortschr Neurol Psychiatr</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="121" to="127" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Inclusion body myositis. Observations in 40 patients</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Lotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nishino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Litchy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="727" to="747" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Familial inclusion body myositis among Kurdish-Iranian Jews</title>
		<author>
			<persName><forename type="first">R</forename><surname>Massa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Weller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Shoubridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="519" to="522" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Hereditary distal myopathy with filamentous inclusions</title>
		<author>
			<persName><forename type="first">S</forename><surname>Matsubara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tanabe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurol Scand</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page">383</biblScope>
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sahenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Paul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1229" to="1234" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Inclusion body myositis in French patients. A clinical pathological evaluation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Mhiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gheradi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropathol Appl Neurobiol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="333" to="344" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<monogr>
		<title level="m" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mikol</surname></persName>
		</author>
		<editor>Myology. McGraw Hill</editor>
		<imprint>
			<date type="published" when="1986">1986</date>
			<biblScope unit="page" from="1423" to="1438" />
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Inclusion-body myositis : clinicopathological studies and isolation of an adenovirus type 2 from muscle biopsy specimen</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mikol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Felten-Papaiconomou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ferchal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Perol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gautier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Haguenau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pepin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="576" to="581" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Familial inclusion body myositis: evidence for autosomal dominant inheritance</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Neville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Baumbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Ringel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sujansky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Garcia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="897" to="902" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Inclusion body myositis : the mumps virus hypothesis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Nishino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Rima</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="260" to="264" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation</title>
		<author>
			<persName><forename type="first">I</forename><surname>Nonaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sunohara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ishiura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Satoyoshi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="141" to="155" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Autosomal recessive distal muscular dystrophy: a comparative study with distal myopathy with rimmed vacuole formation</title>
		<author>
			<persName><forename type="first">I</forename><surname>Nonaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sunohara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Satoyoshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Terasawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yonemoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="51" to="59" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Mumps virus in IBM: studies implicating cross-reactivity accounting for antigen localization</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Rammohan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wolinsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Omerza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kissel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mendell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page">151</biblScope>
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
	<note>Suppl 1</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Inclusion body myositis and chronic immune thrombocytopenia</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Riggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Schochet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gutmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Mccomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Rogers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="93" to="95" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Childhood onset inclusion body myositis mimicking limbgirdle muscular dystrophy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Riggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Schochet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gutmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Lerfald</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Child Neurol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="283" to="285" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Spectrum of inclusion body myositis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Ringel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Kenny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Neville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Giorno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Carry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1154" to="1157" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Myosite/t inclusion, l~tude clinique, morphologique et virologique concernant une nouvelle observation associe6 fi une scl~rodermie g6n~ralis6e et fi un syndrome de Klinefelter</title>
		<author>
			<persName><forename type="first">J</forename><surname>Salama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fms</forename><surname>Tom~</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lebon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Marie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Delaporte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fardeau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Neurol</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="863" to="878" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Formes cliniques des myosites g inclusions: 12 cas</title>
		<author>
			<persName><forename type="first">G</forename><surname>Serratrice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Pellissier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pouget</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Figarella-Branger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Neurol</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="781" to="788" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Distal myopathy with rimmed vacuole formation. A follow up study</title>
		<author>
			<persName><forename type="first">N</forename><surname>Sunohara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nonaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kamei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Satoyoshi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="65" to="83" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<monogr>
		<title level="m" type="main">Ocular myopathies</title>
		<author>
			<persName><forename type="first">Fms</forename><surname>Tom6</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fardeau</surname></persName>
		</author>
		<editor>Myology. McGraw Hill</editor>
		<imprint>
			<date type="published" when="1986">1986</date>
			<biblScope unit="page" from="1327" to="1347" />
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">Fms</forename><surname>Tom6</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fardeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lebon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chevally</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol</title>
		<imprint>
			<biblScope unit="page" from="287" to="291" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
	<note>Suppl VII</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Inclusion body myositis with cricopharyngeus muscle involvement and severe dysphagia</title>
		<author>
			<persName><forename type="first">A</forename><surname>Verma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Bradley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Adesina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sofferman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Pendlebury</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="470" to="473" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Quantitative morphometric study of muscle in inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Verma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Bradley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Soule</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Pendlebury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Adelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Brenner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="192" to="198" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">The idiopathic inflammatory myopathies and their treatment</title>
		<author>
			<persName><forename type="first">J</forename><surname>Walton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Neurosurg Psychiatr</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="285" to="287" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Inclusion body myositis and systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Yood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="568" to="570" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Inclusion body myositis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Yunis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Samaha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lab Invest</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="240" to="248" />
			<date type="published" when="1971">1971</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<monogr>
		<title level="m" type="main">Returned for revision</title>
		<imprint>
			<date type="published" when="1992-11-17">November 17. 1992. January 19. 1993 Accepted: February 5, 1993</date>
		</imprint>
	</monogr>
	<note>Received</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Dr. S. Beyenburg Neurologische Universitfitsklinik Sigmund-Freud-Strasse</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
